Related Experiment Video
Updated: Aug 19, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Insights
Hypothermia and potassium cardioplegia offer superior protection for ischemic myocardium. Immediate induction of cardioplegia and profound cooling to 10°C enhance myocardial preservation during cardiac surgery.
Area of Science:
- Cardiovascular Surgery
- Cardiothoracic Medicine
- Myocardial Protection Strategies
Background:
- Ischemic heart disease poses significant challenges during cardiac surgery.
- Current myocardial protection techniques aim to minimize damage during ischemic periods.
- Optimizing hypothermia and cardioplegia is crucial for improving surgical outcomes.
Purpose of the Study:
- To evaluate the efficacy of combined hypothermia and potassium cardioplegia for myocardial protection.
- To identify key factors influencing the effectiveness of this combined approach.
- To provide recommendations for optimal myocardial protection strategies during cardiac procedures.
Main Methods:
- Utilizing profound hypothermia (systemic perfusate at 20°C, cardioplegic infusate at 4-10°C).
- Employing immediate induction of potassium cardioplegia (15-40 mEq/l) upon onset of ischemia.
- Maintaining cardiac hypothermia via crushed ice or cold electrolyte solution irrigation.
- Comparing outcomes with varying durations of ischemia and potassium reinfusion protocols.
Main Results:
- Combined hypothermia and potassium cardioplegia demonstrate enhanced myocardial protection compared to other methods.
- Profound cooling to 10°C or lower significantly improves myocardial preservation.
- Immediate cardioplegia induction effectively abolishes contractile activity and conserves energy.
- Whole blood as a cardioplegic vehicle offers advantages over asanguinous solutions.
- Safe ischemia durations are defined, with reinfusion protocols established for longer procedures.
Conclusions:
- Hypothermia combined with potassium cardioplegia represents an effective strategy for myocardial protection.
- Optimal myocardial protection involves immediate cardioplegia, profound cooling, and appropriate potassium concentrations.
- Further research may refine the ideal composition of cardioplegic vehicles and precise potassium concentrations.
Abstract:
These data would suggest that hypothermia combined with potassium cardioplegia enhances protection of the ischemic myocardium over other available techniques. The ideal conduct of this myocardial protection is not yet apparent but certain aspects are worthy of emphasis. (1) With the onset of ischemia cardioplegia should be immediately induced to abolish contractile activity and conserve energy. An advantage of blood cardioplegia is that there is no ischemia or it is trivial priorto cardioplegia. (2) The greater the degree of myocardial cooling the better. Although a myocardial temperature of 20 degrees C can commonly be achieved with perfusion hypothermia and topical hypothermia, it is possible to reduce myocardial temperature to 10 degrees C or lower with these same modalities. Because perfusion hypothermia provides fairly uniform rapid myocardial cooling, this should be maximally utilized by cooling of the systemic perfusate to 20 degrees C and cooling the cardioplegic infusate to 4-10 degrees C. Cardiac hypothermia should be maintained with crushed ice made from electrolyte solution or irrigation of the pericardial sac with cold electrolyte solution. The greater the degree of systemic hypothermia the less tendency for the myocardium to warm. (3) The ideal concentration of potassium is unknown at this time with a range of 15-40 mEq/l having been utilized without apparent potassium injury. (4) The ideal composition of the vehicle may never be defined and may not be of great importance. Whole blood would appear to offer physiological and pragmatic advantages over asanguinous vehicles. (5) The safe duration of ischemia has been moderately well defined. 1 h is well tolerated in the dog using profound cardiac hypothermia, whereas 30-45 min with lesser degrees of hypothermia is acceptable. When the interval of ischemia is to be 2 or 3 h reinfusion of potassium every 20-30 min has proven safe both experimentally and clinically.
More Related Videos
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

